Stay Informed

Memory Enhancement Center

↑ Grab this Headline Animator

Enter your email address:

Delivered by FeedBurner

Medical Links

Links

Search


 
Joel S. Ross, MD, FACP, AGSF, CMD President and Founder of Memory Enhancement Center of America
 

Joel S. Ross, MD

MD FACP AGSF CMD CPI
President and Founder
 
Memory Enhancement Center
of America, Inc.
4 Industrial Way West, 2nd Floor
Eatontown, New Jersey 07724
732.571.1535
 
What is Alzheimer's Disease?

Alzheimer’s disease (pronounced AHLZ-hi-merz) is one of several disorders that cause the gradual deterioration of brain cells. The disease is named for Dr. Alois Alzheimer, a German physician who first described the disease in 1906.

The symptoms of Alzheimer’s disease include:

  • a gradual loss of memory
  • problems with learning, reasoning or judgment
  • loss of language skills
  • disorientation
  • a decline in the ability to perform routine tasks.

People with Alzheimer’s disease may also experience changes in their personalities and exhibit behavioral problems such as agitation, anxiety and delusions.

The progression of Alzheimer’s disease varies significantly and can be difficult to predict. The area of the brain that controls memory and thinking skills is affected first, but as the
disease advances, other regions of the brain and the functions they control may also be affected.

According to the Alzheimer’s Association, approximately four million Americans suffer from Alzheimer’s disease. Aging is the major risk factor for the disease, which strikes men
and women in almost equal numbers and affects almost 50 percent of all people 85 and older. A family history of Alzheimer’s disease also increases one’s risk.

The most commonly prescribed medications for Alzheimer’s disease are a class of drugs known as acetylcholinesterase inhibitors. These medications are designed to prevent the
breakdown of acetylcholine, a chemical messenger in the brain that is important for memory and reasoning. Some Alzheimer’s patients who take acetylcholinesterase inhibitors experience a modest but temporary improvement in cognitive functioning. However, Alzheimer’s disease is not yet curable and available treatment neither halts nor reverses
the progression of the illness.